iShares Biotechnology ETF
Health/Biotechnology
IBB
400 Howard Street,
San Francisco , CA, 94105
San Francisco , CA, 94105
Price
-
$ 133.37
0 %
+1.37
May 30, 2024
- Last Close
- Net Assets
-
$7.5B
Feb 27, 2024
- 52-Week High/Low
- $141.2 - $112.41
- Expense Ratio
- -
Link
Directors
Jun 14, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Charles Park
Company Name |
Holding |
| More | 0.03 % |
Documents
Returns +
Q
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Q1 | - | - | 1% | -1.6% | -14.5% | -0.6% |
| Q2 | - | - | -5.3% | -1.7% | -9.7% | 8.9% |
| Q3 | - | - | - | -3.7% | -0.6% | -1.2% |
| Q4 | - | - | - | 12.6% | 12.3% | -5.6% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
Returns +
A
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | -1.8% | 3.5% | -13.9% | 0.8% | 25.7% | 24.7% | -9.5% | 21.1% | -21.4% |